Armis Advisers LLC Makes New $390,000 Investment in Synopsys, Inc. (NASDAQ:SNPS)

Armis Advisers LLC bought a new position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm bought 803 shares of the semiconductor company's stock, valued at approximately $390,000.

Other hedge funds have also made changes to their positions in the company. James Hambro & Partners LLP boosted its stake in shares of Synopsys by 30.9% in the 4th quarter. James Hambro & Partners LLP now owns 201,460 shares of the semiconductor company's stock valued at $97,725,000 after purchasing an additional 47,527 shares during the last quarter. Fiera Capital Corp boosted its stake in shares of Synopsys by 33.8% in the 4th quarter. Fiera Capital Corp now owns 196,391 shares of the semiconductor company's stock valued at $95,320,000 after purchasing an additional 49,653 shares during the last quarter. Bancreek Capital Management LP bought a new position in shares of Synopsys in the 4th quarter valued at about $3,827,000. Meridiem Investment Management Ltd. boosted its stake in shares of Synopsys by 13.1% in the 4th quarter. Meridiem Investment Management Ltd. now owns 557,174 shares of the semiconductor company's stock valued at $270,322,000 after purchasing an additional 64,322 shares during the last quarter. Finally, Symphony Financial Ltd. Co. boosted its stake in shares of Synopsys by 156.4% in the 4th quarter. Symphony Financial Ltd. Co. now owns 1,059 shares of the semiconductor company's stock valued at $569,000 after purchasing an additional 646 shares during the last quarter. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Trading Down 9.6%

Shares of NASDAQ SNPS traded down $49.36 during midday trading on Wednesday, reaching $462.43. The company's stock had a trading volume of 4,790,448 shares, compared to its average volume of 1,121,537. Synopsys, Inc. has a fifty-two week low of $365.74 and a fifty-two week high of $624.80. The stock has a market capitalization of $71.50 billion, a price-to-earnings ratio of 31.85, a PEG ratio of 3.23 and a beta of 1.16. The stock has a 50 day simple moving average of $453.45 and a 200-day simple moving average of $487.42.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The semiconductor company reported $3.67 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $3.40 by $0.27. Synopsys had a net margin of 36.12% and a return on equity of 20.48%. During the same period in the prior year, the firm earned $3.00 EPS. The firm's quarterly revenue was up 10.3% compared to the same quarter last year. As a group, equities analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current year.

Insider Activity at Synopsys

In related news, insider Geus Aart De sold 15,705 shares of the firm's stock in a transaction on Thursday, March 6th. The shares were sold at an average price of $444.42, for a total value of $6,979,616.10. Following the completion of the transaction, the insider now directly owns 116,671 shares of the company's stock, valued at approximately $51,850,925.82. This trade represents a 11.86% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the transaction, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at $32,890,077.50. This represents a 13.81% decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.62% of the stock is owned by company insiders.

Wall Street Analysts Forecast Growth

Several brokerages have recently issued reports on SNPS. Morgan Stanley reduced their target price on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating on the stock in a research note on Monday, February 24th. Bank of America cut their price target on shares of Synopsys from $630.00 to $560.00 and set a "buy" rating on the stock in a research report on Wednesday, April 16th. Rosenblatt Securities reiterated a "buy" rating and issued a $660.00 price target on shares of Synopsys in a research report on Tuesday, February 25th. Wells Fargo & Company cut their price target on shares of Synopsys from $540.00 to $520.00 and set an "equal weight" rating on the stock in a research report on Thursday, February 27th. Finally, Piper Sandler cut their price target on shares of Synopsys from $655.00 to $653.00 and set an "overweight" rating on the stock in a research report on Thursday, February 27th. One investment analyst has rated the stock with a hold rating and twelve have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and an average target price of $614.86.

Synopsys Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.